Clinical Trial Update: Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a Toll-like receptor 7 agonist with cyclophosphamide and radiotherapy for breast cancer with skin metastases has completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• TLR7 agonist (toll-like receptor 7 agonist)

Snippet

Sponsor: NYU Langone Health | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-11-18